SARS News and Research

RSS

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

In this study, the researchers not only elucidate the recent bioconjugated nanomaterials for targeted diagnosis of SARS-CoV-2, but they also provide the rationale behind these developments by discussing the mechanisms and approaches.

18 Jan 2022

Forecasting the temporal evolution of Omicron infections

In a new study, researchers estimated the rate of SARS-CoV-2 Omicron infections by modeling temporal evolution of the Omicron wave.

18 Jan 2022

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

In a new study, researchers analyzed the neutralization of SARS-CoV-2 Omicron and D614G variants before and after subjects received COVID-19 booster vaccinations.

18 Jan 2022

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

The authors highlight that they have shown that boosted individuals are significantly more protected against SARS-CoV-2 infection than any other group

18 Jan 2022

Antibody responses to COVID-19 mRNA vaccines in a cohort of healthcare workers

Researchers have been investigating the vaccine response of healthcare workers from specific vaccines to different variants.

18 Jan 2022

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants

A recent preprint discusses using a combinatorial phage-display library approach to COVIID-19 antibodies.

18 Jan 2022

Machine learning model for prediction of COVID-19 patient mortality risk

A new preprint reports a novel machine learning model that purportedly predicts the mortality risk of COVID-19 in patients accurately and at an early stage of infection.

18 Jan 2022

Immune responses in Omicron breakthrough COVID-19

A recent study examined the question as to whether vaccination protects against Omicron infection by assessing breakthrough infection rates in participants at a superspreader event.

18 Jan 2022

Gaseous ozone is effective for SARS-CoV-2 disinfection

In their recent study published in the Journal of Hazardous Materials, researchers from the United Kingdom have found that ozone as a disinfectant is effective for the inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in liquid cell culture media as well as adhered on surfaces.

18 Jan 2022

An alternative mouse model of SARS-CoV-2 infection

Recently, a study has shown the possibility of repurposing hACE2 transgenic mice, primarily raised to study SARS-CoV, to support SARS-CoV-2 infection and pathogenesis.

17 Jan 2022

Transmission of Omicron in a quarantine hotel between two vaccinated individuals across a corridor

A recent study has reported a community outbreak of imported SARS-CoV-2 Beta variant, owing to intra-hotel transmission in a DQH.

17 Jan 2022

DPP4 protein: The connection between severe COVID-19 and diabetes

Researchers explore the relationship between DPP4 and diabetes targets in the management of COVID-19.

17 Jan 2022

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

A new study discusses the activation of the complement system to determine its role in COVID-19-related deaths.

17 Jan 2022

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Researchers prevent evidence on the efficacy of neutralizing monoclonal antibodies in treating COVID-19.

17 Jan 2022

Effects of post-acute COVID-19 on physical and mental health in women

The current study attempts to measure the difference in mood, functional status, and leisure-time physical activity in women with a history of COVID-19.

17 Jan 2022

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

Researchers determine the driving factors for disease severity and death due to COVID-19.

17 Jan 2022

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Researchers compare the outcomes of the fourth and previous waves of the COVID-19 pandemic in South Africa.

17 Jan 2022

Sniffer dogs detect long COVID after 1.5 years

Researchers used sniffer dogs to test the presence of SARS-CoV-2 infection in axillary sweat samples of long COVID-19 patients.

17 Jan 2022

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Researchers investigate the efficacy of hydroxychloroquine and chloroquine in the treatment of patients hospitalized with COVID-19.

17 Jan 2022

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

New research assesses the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in response to SARS-CoV-2 and its spike protein, and the effects of this exposure in the presence of a-synuclein protein aggregate fibrils.

17 Jan 2022

SARS News and Research

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

Forecasting the temporal evolution of Omicron infections

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

Antibody responses to COVID-19 mRNA vaccines in a cohort of healthcare workers

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants

Machine learning model for prediction of COVID-19 patient mortality risk

Immune responses in Omicron breakthrough COVID-19

Gaseous ozone is effective for SARS-CoV-2 disinfection

An alternative mouse model of SARS-CoV-2 infection

Transmission of Omicron in a quarantine hotel between two vaccinated individuals across a corridor

DPP4 protein: The connection between severe COVID-19 and diabetes

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Effects of post-acute COVID-19 on physical and mental health in women

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Sniffer dogs detect long COVID after 1.5 years

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News